Filings
Finds words inside filing documents. Searching BRAINSTORM CELL THERAPEUTICS INC.'s filings · 33 documents indexed.
16 documents · 33 matches
-
BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-K 2026-03-31
Item 1A. Risk Factors
going concern. Therefore, our ability to continue as a going concern is highly dependent upon us executing our business plan8 matches in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-Q 2026-08-14
Item 1 · Note 1. General
going concern. Management’s plan includes raising funds from outside potential investors, however, as mentioned above, there is no assurance3 matches in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-Q 2026-05-15
Item 1 · Note 1. General
going concern. Management’s plan includes raising funds from outside potential investors, however, as mentioned above, there is no assurance3 matches in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-Q 2025-11-14
Item 1 · Note 1. GENERAL (Cont.):
going concern. Management’s plan includes raising funds from outside potential investors, however, as mentioned above, there is no assurance3 matches in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-Q 2025-08-14
Item 1 · Note 1. GENERAL (Cont.):
going concern. Management’s plan includes raising funds from outside potential investors, however, as mentioned above, there is no assurance3 matches in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-Q 2025-05-15
Item 1 · Note 1. GENERAL (Cont.):
going concern. Management’s plan includes raising funds from outside potential investors via its ATM program and other potential funds3 matches in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 8-K 2026-08-14
going concern, prospects for future regulatory approval of NurOwn, whether BrainStorm’s future interactions with the FDA will have productive1 match in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 8-K 2026-05-28
going concern, prospects for future regulatory approval of NurOwn, whether BrainStorm's future interactions with the FDA will have productive1 match in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 8-K 2026-05-15
going concern, prospects for future regulatory approval of NurOwn, whether BrainStorm’s future interactions with the FDA will have productive1 match in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 8-K 2026-03-31
going concern, prospects for future regulatory approval of NurOwn, whether BrainStorm's future interactions with the FDA will have productive1 match in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 8-K 2025-11-14
going concern, prospects for future regulatory approval of NurOwn, whether BrainStorm's future interactions with the FDA will have productive1 match in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 8-K 2025-08-14
going concern, prospects for future regulatory approval of NurOwn, whether BrainStorm's future interactions with the FDA will have productive1 match in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 8-K 2025-07-17
going concern, prospects for future regulatory approval of NurOwn, whether BrainStorm's future interactions with the FDA will have productive1 match in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 8-K 2025-06-16
going concern, prospects for future regulatory approval of NurOwn, whether BrainStorm's future interactions with the FDA will have productive1 match in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 8-K 2025-05-19
going concern, prospects for future regulatory approval of NurOwn, whether BrainStorm's future interactions with the FDA will have productive1 match in this document -
BCLI BRAINSTORM CELL THERAPEUTICS INC. 8-K 2025-05-15
going concern, prospects for future regulatory approval of NurOwn, whether BrainStorm's future interactions with the FDA will have productive1 match in this document
Page 1 of 1 · 16 documents